Skip to main content
WeightCited

Chromium für Insulin Resistance

B Evidenz Mindestens eine randomisierte Studie unterstützt dies, mit überwiegend konsistenten Ergebnissen.

Meta-analysis of 25 RCTs found significant improvements in fasting glucose (1.16 mmol/L) in type 2 diabetics. Chromium enhances insulin receptor substrate phosphorylation. The ADA notes insufficient evidence for routine recommendation.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Dchromium\u0026condition\u003Dinsulin\u002Dresistance'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

Fazit

Meta-analysis of 25 RCTs found significant improvements in fasting glucose (1.16 mmol/L) in type 2 diabetics. Chromium enhances insulin receptor substrate phosphorylation. The ADA notes insufficient evidence for routine recommendation.

Key Study Findings

Meta-Analysis
Comparative effects of vitamin and mineral supplements in the management of type 2 diabetes in …
Dose: Various vitamins and minerals vs.: Placebo or standard care Outcome: Glycemic control and lipid metabolism Wirkung: None None

Population: T2DM patients in primary care (RCTs)

Review
Non-Hormonal Treatment Options for Regulation of Menstrual Cycle in Adolescents with PCOS.
Dose: None vs.: None Outcome: Menstrual cycle regulation Wirkung: None None

Population: Adolescents with PCOS

Controlled Clinical Trial n=77
Hypoglycemic and Hypolipidemic Effects of Leucine, Zinc, and Chromium, Alone and in Combination, in Rats …
Dose: leucine, zinc, and chromium alone/combined vs.: vehicle-treated T2D rats Outcome: blood glucose and serum lipid profile Wirkung: None <0.05

Population: Male Wistar rats with type 2 diabetes

Key Statistics

25

Studien

2000

Teilnehmer

Positive

B

Bewertung

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Übliche Dosierungen

general:
25-35 mcg/day (AI)
weightmanagement:
200-1,000 mcg/day chromium picolinate
insulinsensitivity:
500-1,000 mcg/day

Obergrenze: No established UL; long-term safety data at >1,000 mcg/day limited

In der Forschung untersuchte Dosierungen

Dosierung Dauer Wirkung N
Various vitamins and minerals -- Positive --
None -- Positive --
leucine, zinc, and chromium alone/combined -- Positive 77

Beste Einnahmezeit: With meals

Safety & Side Effects

Gemeldete Nebenwirkungen

  • Headache
  • Insomnia
  • Mood changes
  • GI discomfort

Bekannte Wechselwirkungen

  • Diabetes medications (may potentiate — hypoglycemia risk)
  • Insulin
  • Sulfonylureas
  • Levothyroxine (reduced absorption)

Tolerierbare Höchstaufnahmemenge: No established UL; long-term safety data at >1,000 mcg/day limited

Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.

Frequently Asked Questions

Does Chromium help with Insulin Resistance?
Based on 25 studies with 2,000 participants, there is moderate evidence from clinical studies that Chromium may support Insulin Resistance management. Our evidence grade is B (Good Evidence).
How much Chromium should I take for Insulin Resistance?
Studies have used various dosages. A commonly studied range is 25-35 mcg/day (AI). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Chromium?
Reported side effects may include Headache, Insomnia, Mood changes, GI discomfort. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Chromium and Insulin Resistance?
We rate the evidence as Grade B (Good Evidence). This rating is based on 25 peer-reviewed studies with 2,000 total participants. The overall direction of effect is positive.

References

  1. [1] Jiayue Xia et al.. Pharmacol Res. 2023. Comparative effects of vitamin and mineral supplements in the management of type 2 diabetes in primary care: A systematic review … doi:10.1016/j.phrs.2023.106647 PubMed
  2. [2] Elisabeth Reiser et al.. J Clin Med. 2022. Non-Hormonal Treatment Options for Regulation of Menstrual Cycle in Adolescents with PCOS. doi:10.3390/jcm12010067 PubMed
  3. [3] Hassan Sadri et al.. Biol Trace Elem Res. 2017. Hypoglycemic and Hypolipidemic Effects of Leucine, Zinc, and Chromium, Alone and in Combination, in Rats with Type 2 Diabetes. doi:10.1007/s12011-017-1014-2 PubMed

FDA-Haftungsausschluss: Diese Aussagen wurden nicht von der Food and Drug Administration bewertet. Die Produkte und Informationen auf dieser Website sind nicht dazu bestimmt, Krankheiten zu diagnostizieren, zu behandeln, zu heilen oder zu verhindern. Die dargestellten Evidenzbewertungen basieren auf unserer Analyse veröffentlichter begutachteter Forschung und stellen keine medizinische Beratung dar. Konsultieren Sie immer Ihren Arzt, bevor Sie mit der Einnahme von Nahrungsergänzungsmitteln beginnen.